Fehse B - Search Results

1

Correction: Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application.

Schwarze LI, Głów D, Sonntag T, Uhde A, Fehse B. Schwarze LI, et al. Among authors: fehse b. Gene Ther. 2023 Feb;30(1-2):187. doi: 10.1038/s41434-022-00373-y. Gene Ther. 2023. PMID: 36418432 Free PMC article. No abstract available.

2

Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene.

Fehse B, Uhde A, Fehse N, Eckert HG, Clausen J, Rüger R, Koch S, Ostertag W, Zander AR, Stockschläder M. Fehse B, et al. Among authors: fehse n. Hum Gene Ther. 1997 Oct 10;8(15):1815-24. doi: 10.1089/hum.1997.8.15-1815. Hum Gene Ther. 1997. PMID: 9358031

3

Impact of a new generation of gene transfer markers on gene therapy.

Fehse B, Li Z, Schade UM, Uhde A, Zander AR. Fehse B, et al. Gene Ther. 1998 Apr;5(4):429-30. doi: 10.1038/sj.gt.3300666. Gene Ther. 1998. PMID: 9614565 No abstract available.

4

Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin.

Fehse B, Schade UM, Li Z, Uhde A, Koch S, Goller B, Rüger R, Fehse N, Stockschläder M, Zander AR. Fehse B, et al. Among authors: fehse n. Br J Haematol. 1998 Jul;102(2):566-74. doi: 10.1046/j.1365-2141.1998.00785.x. Br J Haematol. 1998. PMID: 9695974 Free article.

5

High-efficiency retroviral vector-mediated gene transfer into human T lymphocytes.

Li ZX, Schade UM, Fehse B, Stockschläder M, Uhde A, Koch S, Goller B, Rüger R, Fehse N, Zander AR. Li ZX, et al. Among authors: fehse b, fehse n. Adv Exp Med Biol. 1998;451:375-8. doi: 10.1007/978-1-4615-5357-1_58. Adv Exp Med Biol. 1998. PMID: 10026899 No abstract available.

6

Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis.

Weber K, Mock U, Petrowitz B, Bartsch U, Fehse B. Weber K, et al. Among authors: fehse b. Gene Ther. 2010 Apr;17(4):511-20. doi: 10.1038/gt.2009.149. Epub 2009 Dec 17. Gene Ther. 2010. PMID: 20016542

7

Efficient lentiviral transduction and transgene expression in primary human B cells.

Mock U, Thiele R, Uhde A, Fehse B, Horn S. Mock U, et al. Among authors: fehse b. Hum Gene Ther Methods. 2012 Dec;23(6):408-15. doi: 10.1089/hgtb.2012.160. Hum Gene Ther Methods. 2012. PMID: 23240650

8

TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer.

Berdien B, Mock U, Atanackovic D, Fehse B. Berdien B, et al. Among authors: fehse b. Gene Ther. 2014 Jun;21(6):539-48. doi: 10.1038/gt.2014.26. Epub 2014 Mar 27. Gene Ther. 2014. PMID: 24670996

9

Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors.

Trepel M, Körbelin J, Spies E, Heckmann MB, Hunger A, Fehse B, Katus HA, Kleinschmidt JA, Müller OJ, Michelfelder S. Trepel M, et al. Among authors: fehse b. Gene Ther. 2015 Oct;22(10):840-7. doi: 10.1038/gt.2015.52. Epub 2015 Jun 2. Gene Ther. 2015. PMID: 26034897

10

SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model.

Täger M, Horn S, Latuske E, Ehm P, Schaks M, Nalaskowski M, Fehse B, Fiedler W, Stocking C, Wellbrock J, Jücker M. Täger M, et al. Among authors: fehse b. Gene Ther. 2017 Nov;24(11):749-753. doi: 10.1038/gt.2017.88. Epub 2017 Nov 16. Gene Ther. 2017. PMID: 29143813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters